For release: 07.00, 31 December 2024
EMV Capital
plc
(EMVC, Group
or the Company)
Q-bot Limited (Q-Bot)
Fundraising
Issue of Shares and Total
Voting Rights
EMV Capital plc (AIM: EMVC), the
deeptech and life sciences VC investment group, announces that
further to its announcement of 3 December 2024, Q-Bot has completed
the first closing of its £1.3 million fundraising programme, with
an investment value of £0,63 million (Fundraising).
The Fundraising was led and
syndicated by EMV Capital Partners Limited, the Company's wholly
owned venture capital and corporate finance firm, and includes
third party loan monies of £0.1 million pursuant to an extended
existing facility agreement, convertible loan monies of £0.51
million pursuant to new convertible loan agreements (CLAs) and advance subscription monies
of £0.02 million pursuant to advance subscription agreements
(ASAs).
Further to the announcement on 3
December 2024, the Group has participated directly in the
Fundraising by investing in a CLA as to a total of c.£350,000 as
follows:
· as to c.£250,000,
by issuing to Q-Bot 409,836 new ordinary shares in the capital of
the Company (Consideration
Shares) at a price of £0.61 per New Share, a 25.5 per cent.
premium to the closing price of the Company's ordinary shares on 30
December 2024; and
· as to c.£100,000 by
releasing Q-Bot from outstanding fees due to the Group in respect
of services provided.
The terms of the CLA
include:
· interest accruing at 14 per cent. per annum;
· an 18
month maturity date;
·
the Group having the
ability to convert some or all of the CLA monies into equity in
Q-Bot at a 70 per cent. discount to the next Q-Bot fundraising
round (conversion being at the discretion of the Group other than
where Q-Bot raises £3 million, in which case conversion is
mandatory); and
·
the Consideration Shares are
subject to orderly market provisions, including that if they are to
be disposed of by Q-Bot they must be sold through the Company's
broker.
As previously announced, as the
Fundraising does not establish a fixed price for Q-Bot's shares
(given that the conversion price of the convertible instruments is
contingent upon factors such as a subsequent fundraising round, an
exit event, or the maturity date), the Directors are unable to
estimate any changes to the current fair value of Q-Bot as a
consequence of the Fundraising. However, in the absence of
significant growth prior to its next equity fundraising, it is
anticipated that the fair value of Q-Bot could be materially lower
than the previously reported figure (direct equity holding of 17.0
per cent. with a fair value of £2.7 million; and other AUM equity
holding of 37.4 per cent. with a fair value of £6.0
million).
Admission of Consideration Shares and Total Voting
Rights
Application will be made for the
Consideration Shares, which will rank pari passu with existing
Ordinary Shares, to be admitted to AIM (Admission). It is expected that
Admission will become effective and dealings will commence at 8.00
a.m. on or around 3 January 2025.
Following Admission, the total
issued share capital of the Company will consist of 27,767,391
Ordinary Shares. The Company does not hold any shares in treasury.
Therefore, the total number of voting rights in the Company will be
27,767,391 Ordinary Shares. This number may be used by shareholders
as the denominator for the calculations by which they will
determine if they are required to notify their interest, or a
change to their interest in, the Company under the FCA's Disclosure
Guidance and Transparency Rules.
The person responsible for arranging the release of this
announcement on behalf of the Company is Ed Hooper, Executive
Director and General Counsel of the Company.
THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES
OF ARTICLE 7 OF THE UK VERSION OF REGULATION (EU) NO 596/2014 WHICH
IS PART OF UK LAW BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT
2018, AS AMENDED. UPON THE PUBLICATION OF THIS ANNOUNCEMENT VIA A
REGULATORY INFORMATION SERVICE, THIS INSIDE INFORMATION IS NOW
CONSIDERED TO BE IN THE PUBLIC DOMAIN.
-Ends-
For
more information, please contact:
|
EMV
Capital plc
|
via Rosewood
|
Ilian Iliev, CEO
|
|
|
|
Panmure Liberum (UK) Limited (NOMAD and Broker)
|
+44 (0)20 7886 2500
|
Emma Earl / Will Goode / Freddy
Crossley / Mark Rogers (Corporate Finance)
|
|
Rupert Dearden (Corporate
Broking)
|
|
|
|
Rosewood (Financial
PR)
|
+44 (0)20 7653 8702
|
John West / Llewellyn Angus / Lily Pearce
|
|
About EMV Capital plc (EMVC)
EMV Capital plc, formerly known as
NetScientific plc, is a deep tech and life sciences venture capital
investment group with an international portfolio of high-growth
companies.
With a strategic focus on generating
superior returns for investors from the fast-growing sectors and
technologies that will define our future; EMV Capital invests in,
manages and strengthens early stage IP-rich companies.
EMV Capital holds both direct equity
stakes and carried interest in its portfolio companies, creating an
evergreen structure that supports extensive growth and value
creation. EMV Capital's investment thesis is realised through these
capital sources:
·
capital-efficient investments through Group
balance sheet;
·
fund management of the Evergreen EIS and Martlet
Capital Funds;
·
syndicated investments leveraging its network of
third-party investors.
EMV Capital's approach is
characterised by its proactive management style, aiming to advance
portfolio companies to critical value inflection points by actively
engaging with them. Companies are supported through Board
representation and the use of its Value Creation Services
practice.
Headquartered in London, with a
Cambridge presence and strong international links, EMV Capital is
quoted on the AIM market of the London Stock Exchange.
For more information, visit
www.emvcapital.com